Objective: To study the association between paternal medical comorbidities and the outcomes of assisted reproductive technology (ART). Design: Retrospective cohort study. Setting: Academic reproductive medicine center. Patient(s): We analyzed fresh ART cycles uszing freshly ejaculated sperm from the male partner of couples undergoing ART cycles from 2004 until 2014. We recorded patient and partner demographic characteristics. The cohort was linked to hospital billing data to obtain information on selected male partners' comorbidities identified using ICD-9-CM codes. Intervention(s): None. Main Outcome Measure(s): Fertilization, clinical pregnancy, miscarriage, implantation, and live-birth rates as well as birth weights and gestational ages. Result(s): In all, we identified 2,690 men who underwent 5,037 fresh ART cycles. Sixty-seven percent of men had at least one medical diagnosis. Men with nervous system diseases had on average lower pregnancy rates (23% vs. 30%) and live-birth rates (15% vs. 23%) than men without nervous system diseases. Lower fertilization rates were also observed among men with respiratory diseases (61% vs. 64%) and musculoskeletal diseases (61% vs. 64%) relative to those without these diseases. In addition, men with diseases of the endocrine system had smaller children (2,970 vs. 3,210 g) than men without such diseases. Finally, men with mental disorders had children born at an earlier gestational age (36.5 vs. 38.0 weeks). Conclusion(s): The current report identified a possible relationship between a man's health history and IVF outcomes. As these are potentially modifiable factors, further research should determine whether treatment for men's health conditions may improve or impair IVF outcomes.
Use your smartphone to scan this QR code and connect to the discussion forum for this article now.* * Download a free QR code scanner by searching for "QR scanner" in your smartphone's app store or app marketplace.
A berrations in reproductive fitness may be a harbinger of medical diseases in men. For example, most studies demonstrate that obesity and tobacco use impair semen quality (1, 2) . Indeed, infertile men have higher rates of medical comorbidities compared with fertile controls (3) . Moreover, a recent study found an association of medical comorbidity and medication use with reduced semen quality (4) . Little is known about how a man's somatic health influences fertility outcomes.
Evidence suggests that a woman's health can impact her fertility. Obesity, diabetes, and thyroid disease are some of the factors that have been shown to impair reproductive outcomes (5) (6) (7) . However, limited data suggest that male factors may affect the outcomes of assisted reproductive technology (ART). Some but not all studies of paternal age suggest adverse effects on IVF success (8, 9) . Male obesity also has uncertain effects on male fertility and IVF outcomes (10) (11) (12) (13) (14) . One report of eight couples with a diabetic male partner reported lower pregnancy rates but similar fertilization rates compared with cycles performed among couples with nondiabetic men (15) . To date, no study has examined the association between a man's overall health and IVF outcomes. Given that somatic health has been shown to influence semen quality, we sought to determine the relationship between a man's medical comorbidities and IVF outcomes.
METHODS Study Population
After Institutional Review Board approval, we identified couples undergoing IVF cycles at the Stanford Fertility and Reproductive Health Center from January 2004 until 2014. We examined only IVF cycles using fresh ejaculated sperm from the male partner for whom complete outcome data were available. We recorded patient and partner demographic characteristics from standard cycle data collection. The cohort was linked to hospital billing data to obtain information on the male partners' comorbidities identified using ICD-9-CM codes and limited to men evaluated within the health care system. Neoplasms were defined as codes 140-239.9; endocrine, nutritional, metabolic, and immunity disorders as codes 240-279.9; diseases of the blood and blood-forming organs as 280-289.9; mental health disorders as 290-319; diseases of the nervous system and sense organs as 320-389.9; diseases of the circulatory system as 390-459.9 (excluding 456.4; varicocele was excluded given its strong association with male factor infertility); diseases of the respiratory system as 460-519.9; diseases of the digestive system as 520-579.9; diseases of the genitourinary system as 580-629.9; diseases of the skin and SC tissue as 680-709.9; and diseases of the musculoskeletal system and connective tissue as 710-739.9. The score on the Charlson Comorbidity Index (CCI) was calculated using the modifications of Quan et al. (16) .
Outcome Ascertainment
Cycle outcomes were queried from the Stanford IVF clinical database. We calculated fertilization rate (number of embryos derived per oocyte injected or inseminated), clinical pregnancy rate (fetal heartbeat on ultrasound per IVF cycle started), miscarriage rate (spontaneous abortion per IVF cycle started), implantation rate (gestational sacs per embryo transferred), live-birth rate (births per IVF cycle started), singleton birth weight, and gestational age at singleton delivery.
Data Analysis
Associations between selected medical history variables and binary outcome variables (i.e., pregnancy, miscarriage, implantation, and live-birth rates) were modeled using generalized estimating equation models; continuous outcome variables (i.e., fertilization rate, birth weight, and gestational age) were analyzed using mixed effects linear regression models. All models allowed a man to contribute more than one IVF cycle to the analysis. 
RESULTS
In all, we identified 2,690 men who had outpatient data available. Table 1 ). Of the 59% of men with available data on race, 46% were Caucasian. Twenty-seven percent of men had at least one medical diagnosis, and 15% had two or more diagnoses. Ninety-six percent of men had a CCI of 0. There was no significant association between the diagnosis of male factor infertility and medical comorbidity. After stratifying by organ system and controlling for the covariates described above, differences were noted for ART outcomes based on any medical condition in the male partner ( Table 2) . Men with nervous system diseases had partners with lower pregnancy rates (23% vs. 30%; P¼ .04) and live-birth rates (15% vs. 23%; P< .01) relative to men without nervous system diseases. Men with respiratory diseases (61% vs. 64%; P¼ .03) and musculoskeletal diseases (61% vs. 64%; P< .01) had partners with lower fertilization rates than men without these diseases. In addition, men with at least one comorbidity had partners with lower fertilization rates than men with no comorbidities (64% vs. 63%; P¼ .02). Men with endocrine diseases had partners with a higher implantation rate (70% vs. 60%; P¼ .04) compared with men without endocrine disorders. The associations were similar for unadjusted and adjusted models. When examining cycles restricted to IVF only, some differences were identified based on male comorbidities (Table 3) . Men with genitourinary diseases (54% vs. 62%; P¼ .047) and musculoskeletal diseases (58% vs. 62%; P¼ .02) had partners with a lower fertilization rate than men without these respective diseases. Among IVF only cycles, men with diseases of the circulatory system also had partners with a higher miscarriage rate than men without such diseases (13% vs. 6%; P¼ .02). When examining infant birth weights and gestational age at delivery, there was little evidence of an association overall, but we identified associations with certain male comorbidities (Table 4) . Among couples using ART, men with diseases of the endocrine, nutritional, or metabolic systems were more likely to have low birth weight infants than men without such diseases (2,970 vs. 3,210 g; P¼ .02). In addition, after examining singleton births conceived after IVF alone, men with endocrine and genitourinary diseases had infants with lower birth weights than men without such diagnoses (3,070 vs. 3,190 g; P¼ .02 and 2,720 vs. 3,190 g; P¼ .02; respectively). Among couples using IVF with or without ICSI, men with mental health disorders were more likely to have infants born at an earlier gestational ages (36.5 vs. 38.0 weeks, P¼ .045) than men without mental health disorders. This same trend was also identified after restriction to couples using IVF without ICSI (36.0 vs. 38.1 weeks; P¼ .057).
DISCUSSION
The current report identified a relationship between a man's somatic health history and ART outcomes, including altered fertilization, pregnancy, miscarriage, implantation, and live-birth rates. These associations differed by whether or Note: Birth weight models adjusted for male age, female age, year, female smoking, race, number of eggs retrieved, number of embryos transferred, prior pregnancy, and gestational age at delivery. Gestational age models adjusted for male age, female age, year, female smoking, race, number of eggs retrieved, number of embryos transferred, and prior pregnancy. not ICSI cycles were included. In addition, significant decreases in infant birth weights were identified among men with endocrine or genitourinary diseases. Gestational age at delivery was noted to be lower among men with mental health disorders. To our knowledge, this is the first report to explore links between a man's somatic health and ART outcomes. Prior data suggest a man's health can impact sperm production. Using a similar design to the current report, our own group reported an association between a man's health and semen parameters (4) . Diseases of particular organ systems such as cardiovascular, endocrine, and skin were associated with significant impairments in sperm production. Salonia and colleagues performed a case-control study of infertile and fertile men and showed that infertile men had higher rates of medical comorbidity (3). Diabetes and hyperlipidemia have also been associated with male factor infertility (17) (18) (19) (20) .
To date, little data exist on which, if any, male factors may impact IVF outcomes. Some but not all studies show that advanced paternal age adversely affects IVF success (8, 9) . Male obesity also has uncertain effects on male fertility and IVF outcomes, with several studies demonstrating an impairment with reproduction and others showing no association (10) (11) (12) (13) (14) . It is important to note that the diagnostic categories examined in the current report are broad and not generally used in direct patient care.
The etiology of the inverse relationship between a man's health and ART outcomes is unknown. Recent studies have demonstrated that the epigenetic profile of sperm can influence early embryo development (21) . As aging and exposures can influence the epigenome, it is conceivable that epigenetic influences may link a man's health to IVF cycle and birth outcomes (22, 23) . However, the current report found no association between a diagnosis of ''male factor'' and men's health, suggesting limitations with the current male infertility coding system as has been demonstrated in a previous analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System database (24) .
While biologic plausibility exists and several associations with health were identified, it is important to note than many were modest. In fact, given the known impact of a man's health on semen quality and a woman's health on IVF outcomes, one may expect a more profound impact of male health on ART outcomes. Several possible explanations exist. First, it is conceivable that most aspects of man's health may not be related to the success of his gametes in IVF. The techniques of ART are quite powerful and can overcome many limitations of severe male factor. While higher semen quality may impact the likelihood of fertilization through intercourse, the artificial environment of IVF may be able to bypass the transportation limits (i.e., low motility, low concentration, and so on) caused by male factor infertility. Indeed, Gaskins et al. also reported no association between improvements in semen quality brought about by physical activity and fertility treatment outcomes (25) .
Several other limitations warrant mention. As with all analyses of administrative data sets, more detailed information about potential confounders was not available. Unmeasured or residual confounding by common causes of poor somatic health and infertility could explain the associations we observed. For example, poor diet, sedentariness, obesity, medication use, and exposure to environmental chemicals could adversely affect somatic health and infertility and could have confounded the results. The causes for a couple's infertility are variable, and, while we attempted to account for female factors in our analysis, other factors may have confounded our results. Moreover, given our sample size, we could not eliminate all female causes of infertility. In addition, our study may have been underpowered to identify an effect for less common conditions. While we did identify isolated lower pregnancy rates in partners of men with medical problems compared with those without, few reached statistical significance. Given the high success rates of IVF, large numbers may be required to identify modest associations for medical conditions with lower prevalence (e.g., blood disorders), especially given the health of reproductive age men (3, 26) . As with all analyses of administrative data sets, more detailed information about the medical history of men could be not be assessed, which also may limit the current analysis. For example, we were unable to assess whether body mass index or medication use for the various medical conditions explained the observed associations. In addition, diagnostic coding was dependent upon the accuracy of any of the treating physicians caring for each man. As such, diagnoses may have been missed if not evaluated. However, prior data suggest good specificity for ICD-9 codes in identifying men with a given disease, and there is little reason to believe that the coding was dependent on IVF outcomes (27) . Moreover, several hypotheses were tested, as was the goal for our exploratory analysis, thereby increasing the potential for false-positive associations. Therefore, we cannot exclude the possibility that chance alone led to our findings. As these couples were all using IVF, the results may not be generalizable to couples attempting to conceive without assistance.
Nevertheless, the current report is the first assessment of the impact of a man's overall health on IVF outcomes. In addition to the importance of a man's health for longevity, vitality, and semen production, our data suggest that a man's health status may also be associated with ART success and birth characteristics of the child. As male comorbidities are potentially modifiable factors, further research should determine whether treatment for men's health conditions may influence IVF outcomes.
